Procalcitonin as a marker for the diagnosis of sepsis


  • C. G. Chivate Department of Medicine, BVDUMC & H Sangli, Maharashtra
  • G. J. Belwalkar Department of Biochemistry, BVDUMC & H Sangli, Maharashtra
  • R. P. Limaye Department of Pharmacology, BVDUMC & H Sangli, Maharashtra
  • Rahul V. Patil Department of Medicine, BVDUMC & H Sangli, Maharashtra



Procalcitonin, Sepsis


Background: Quick diagnosis of sepsis in intensive care unit patients is challenging for physicians.

Methods: The prospective study was conducted at our hospital. We studied the efficacy of procalcitonin as a marker of sepsis in 87 adults admitted to our intensive care unit with symptoms of systemic infection. The study samples included all patients aged above 18 years with acute sepsis. Statistical analyses were done using SPSS. PCT and various other relevant factors were measured in all study subjects. PCT levels of less than 0.1 ng/ml were considered negative; all other levels were considered positive.

Results: PCT proved to be an excellent indicator of sepsis. Serum PCT levels predicts mortality in the present study.

Conclusions: PCT is among the most promising sepsis markers capable of completing clinical signs and routine lab parameters suggestive of severe infection.


Wacher C, Brunkhorst FM. Procalcitonin as a diagnostic marker for sepsis. The Lancet Infectious Diseases. 2013;13;5:426-35.

Chaudhury A, Rao TV. Bacteremia in a tertiary care urban hospital in South India. Indian J Pathol Microbiol. 1999;42:17-20.

Riedel S, Melendez MS, Amanda T, Janet E. Rosenbaum. Procalcitonin as a marker for the detection of Bacteremia and sepsis in the emergency department. American Journal of Pathology. 2011;135:182-9.

Sinha M, Desai S, Mantri S, Kulkarni A. Procalcitonin as an adjunctive biomarker in sepsis. Indian J Anaesth. 2011;55:266-70.

Becker KL, Snider R, Nylen ES. Procacot. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. British journal of Pharmacology. 2010;159:253-64.

Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemiiother. 2011;66(2):ii33-ii40.

Prkno A, Wacker C, Brunkhorst FM, Schlsttmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock- a systematic review and meta- analysis. Critical care. 2013;17:R291.

Simon P, Mibrandt EB, Emlet LL. Procalcitonin - guided antibiotics in severe sepsis. Critical care. 2008;12:309.

Jin M, Khan A. Procalcitonin uses in the clinical laboratory for the diagnosis of sepsis. Lab Med.


Meisner M. The prognostic value of PCT: Procalcitonin (PCT) - A new innovative infection parameter. Biochemical and clinical aspects. 3rd ed. New York: Thieme Publishers. 2000:63-8.

Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of severe sepsis in the United States from1979 through 2000. N Engl J Med. 2003;348:1546-54.

Sand KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL. Epidemiology of sepsis syndrome in 8 academic medical centres. JAMA. 1997;278:234-40.

Todi S, Chatterjee S, Bhattacharyya M. Epidemiology of severe sepsis in India. Crit Care Med. 2007;11:65.

Calandra T, Cohen J. International sepsis forum definition of infection in the ICU consensus conference. Crit Care Med. 2005;33:1538-48.

Sudhir U, Venkatachalaiah RK, Thimmaiah AK, Rao MY, Kempegowda P. Significance of serum Procalcitonin in sepsis. Indian Journal of Critical Care Medicine. 2011;15(1):1-5.




How to Cite

Chivate, C. G., Belwalkar, G. J., Limaye, R. P., & Patil, R. V. (2016). Procalcitonin as a marker for the diagnosis of sepsis. International Journal of Research in Medical Sciences, 4(4), 1216–1218.



Original Research Articles